Jones E - Search Results

1

Defining High Endothelial Venules and Tertiary Lymphoid Structures in Cancer.

Jones E, Gallimore A, Ager A. Jones E, et al. Methods Mol Biol. 2018;1845:99-118. doi: 10.1007/978-1-4939-8709-2_7. Methods Mol Biol. 2018. PMID: 30141010

2

Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered.

Bachmann MF, Gallimore A, Jones E, Ecabert B, Acha-Orbea H, Kopf M. Bachmann MF, et al. Among authors: jones e. Eur J Immunol. 2001 Feb;31(2):450-8. doi: 10.1002/1521-4141(200102)31:2<450::aid-immu450>3.0.co;2-x. Eur J Immunol. 2001. PMID: 11180109 Free article.

3

Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment.

Leung RK, Thomson K, Gallimore A, Jones E, Van den Broek M, Sierro S, Alsheikhly AR, McMichael A, Rahemtulla A. Leung RK, et al. Among authors: jones e. Nat Immunol. 2001 Dec;2(12):1167-73. doi: 10.1038/ni733. Nat Immunol. 2001. PMID: 11694883

4

Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.

Smith DC, Gallimore A, Jones E, Roberts B, Lord JM, Deeks E, Cerundolo V, Roberts LM. Smith DC, et al. Among authors: jones e. J Immunol. 2002 Jul 1;169(1):99-107. doi: 10.4049/jimmunol.169.1.99. J Immunol. 2002. PMID: 12077234

5

Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies.

Simon AK, Gallimore A, Jones E, Sawitzki B, Cerundolo V, Screaton GR. Simon AK, et al. Among authors: jones e. Cancer Cell. 2002 Oct;2(4):315-22. doi: 10.1016/s1535-6108(02)00151-4. Cancer Cell. 2002. PMID: 12398895 Free article.

6

CD25+ regulatory T cells and tumor immunity.

Jones E, Dahm-Vicker M, Golgher D, Gallimore A. Jones E, et al. Immunol Lett. 2003 Jan 22;85(2):141-3. doi: 10.1016/s0165-2478(02)00240-7. Immunol Lett. 2003. PMID: 12527220 Review.

7

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens.

Golgher D, Jones E, Powrie F, Elliott T, Gallimore A. Golgher D, et al. Among authors: jones e. Eur J Immunol. 2002 Nov;32(11):3267-75. doi: 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1. Eur J Immunol. 2002. PMID: 12555672 Free article.

8

The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells.

Jones E, Price DA, Dahm-Vicker M, Cerundolo V, Klenerman P, Gallimore A. Jones E, et al. Immunology. 2003 May;109(1):68-75. doi: 10.1046/j.1365-2567.2003.01636.x. Immunology. 2003. PMID: 12709019 Free PMC article.

9

Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice.

Jones E, Dahm-Vicker M, Simon AK, Green A, Powrie F, Cerundolo V, Gallimore A. Jones E, et al. Cancer Immun. 2002 Feb 22;2:1. Cancer Immun. 2002. PMID: 12747746

10

Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression.

Probst HC, Tschannen K, Gallimore A, Martinic M, Basler M, Dumrese T, Jones E, van den Broek MF. Probst HC, et al. Among authors: jones e. J Immunol. 2003 Nov 15;171(10):5415-22. doi: 10.4049/jimmunol.171.10.5415. J Immunol. 2003. PMID: 14607945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,410 results

Search Page

Filters